2Marjo HT, Mattie L, William W, et al. Patients enrolled in coronary intervention trials are not representative of patients in clinical practice:results from the Euro Heart Survey on Coronary Revascularization[J].Eur Heart J,2006,27:671-678.
3de Winter RJ, Windhausen F, Cornel JH, et al. Early invasive versus selectively invasive management for acute coronary syndromes [J]. N Engl J Med,2005,353:1095-1104.
4Giuseppe DL,Harry S, Felix Z, et al. Symptom-onset-to-balloon time and mortality in patients with acute myocardial infarction treated by primary angioplasty [J]. J Am Coil Cardiol, 2003,42: 991-997.
5Cannon CP, Gibson CM, Lambrew CT, et al. Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction [J]. JAMA, 2000, 283 : 2941-2947.
6Andersen HR, Nielsen TT, Rasmussen K, et al. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction[J]. N Engl J Med,2003,549:733-742.
7Kaul P, Chang WC, Lincoff AM, et al. Optimizing use of revascularization and clinical outcomes in ST-elevation myocardial infarction: insights from the GUSTO-V trial[J]. Eur Heart J,2006, 27 : 1198-1206.
